Salud financiera de hoja de balance de Pediatrix Medical Group
Salud financiera controles de criterios 3/6
Pediatrix Medical Group tiene un patrimonio de accionistas total de $849.1M y una deuda total de $624.1M, lo que sitúa su ratio deuda-patrimonio en 73.5%. Sus activos y pasivos totales son $2.2B y $1.4B respectivamente. El BAIT de Pediatrix Medical Group es de $157.9M, por lo que su ratio de cobertura de intereses es de 4.2. Tiene efectivo e inversiones a corto plazo que ascienden a $177.7M.
Información clave
73.5%
Ratio deuda-patrimonio
US$624.09m
Deuda
| Ratio de cobertura de intereses | 4.2x |
| Efectivo | US$177.74m |
| Patrimonio | US$849.06m |
| Total pasivo | US$1.37b |
| Activos totales | US$2.22b |
Actualizaciones recientes sobre salud financiera
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Recent updates
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06Does MEDNAX (NYSE:MD) Have A Healthy Balance Sheet?
Mar 14Returns On Capital At MEDNAX (NYSE:MD) Paint An Interesting Picture
Feb 15
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($483.5M) de MD superan a sus pasivos a corto plazo ($388.9M).
Pasivo a largo plazo: Los activos a corto plazo ($483.5M) de MD no cubren sus pasivos a largo plazo ($981.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de MD (52.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de MD ha crecido de 63.9% a 73.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de MD está bien cubierta por el flujo de caja operativo (22%).
Cobertura de intereses: Los pagos de intereses de la deuda de MD están bien cubiertos por el BAIT (4.2x cobertura).